Biographical Sketch
Dr. Laurence Kennedy has been appointed as Chairman of Endocrinology, Diabetes, and Metabolism Department as of April 2009.
Dr Kennedy graduated from medical school at Queens University, Belfast, Northern Ireland, in 1972. He completed his medical residency and clinical endocrine training at the teaching hospitals in Belfast before coming to the US in 1978 as a research fellow in endocrinology at University of Florida, Gainesville. His research was in the field of glycation of proteins "hemoglobin, plasma proteins, collagen" and the relationship with complications of diabetes mellitus.
After returning to Belfast in 1980 he was on the faculty of the Royal Victoria Hospital, the main teaching hospital in Belfast, where he continued his clinical research activities in the diabetes field and also in pituitary disease and Cushing's syndrome.
He returned to the US in the mid 1990s, and was Chief of the Endocrine Division at the University of Florida for approximately 10 years.
Dr Kennedy has approximately 100 original publications in peer-reviewed journals. He currently serves as Chair of the Grant Review Committee of the American Diabetes Association, and is on the Editorial Board of Diabetes Care.
Specialty Interests
Adrenal disorders, Diabetes, diabetes and diabetes complications, diabetes mellitus, Flushing Syndromes, general endocrinology, Hirsutism, hyperlipidemia, including pituitary and adrenal diseases, Lipid Disorders, Metabolic Syndrome, multiple endocrine neoplasia syndromes, Obesity, Osteoporosis, pituitary and adrenal disorders, pituitary disease, Prolactin Excess States, thyroid, thyroid disease, type 1 diabetes
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Kennedy’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.
